↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

77 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abatacept   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 2   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 3   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 4   Alendronate   Alendronic acid   D00939, D07119   1件: FDPS   1件: Terpenoid backbone biosynthesis   7件:
19,
41,
46,
50,
271,
274,
299 
 5   Alendronate versus alfacalcidol (1-alpha oh vitamin d)   Alendronic acid, Alfacalcidol, Vitamin D   D00939, D01518, D07119   2件: FDPS, VDR   3件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Terpenoid backbone biosynthesis   3件:
41,
46,
50 
 6   Alfacalcidol   Alfacalcidol   D01518   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   6件:
41,
46,
49,
50,
96,
235 
 7   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 8   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 9   Baricitinib   Baricitinib   D10308   2件: JAK1, JAK2   3件: Chemokine signaling pathway, JAK-STAT signaling pathway, Osteoclast differentiation   8件:
41,
46,
49,
50,
93,
107,
265,
325 
 10   Blood samples   -   -   -   -   8件:
13,
41,
46,
51,
61,
97,
227,
271 
 11   Bosentan   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   9件:
13,
41,
47,
51,
84,
85,
86,
88,
210 
 12   Bosentan mylan   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   1件:
41 
 13   Cnto 136   -   -   -   -   1件:
41 
 14   Cortancyl   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
35,
41,
162 
 15   Cortancyl ® 1 mg   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
41 
 16   Cortancyl ® 20 mg   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
41 
 17   Cortancyl ® 5 mg   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
41 
 18   Corticoids+ tocilizumab 8mg/kg/4 weeks   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   1件:
41 
 19   Corticosteroid (cs)   -   -   -   -   1件:
41 
 20   Corticosteroids   -   -   -   -   9件:
41,
46,
49,
64,
97,
164,
220,
296,
300 
 21   Corticosteroids for systemic use   -   -   -   -   1件:
41 
 22   Cosentyx   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   3件:
41,
269,
271 
 23   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 24   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 25   Dotatate   Dotatate   -   -   -   3件:
41,
75,
84 
 26   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 27   Gevokizumab   Gevokizumab   D09911   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   4件:
41,
50,
56,
269 
 28   Glucocorticoid treatment   -   -   -   -   1件:
41 
 29   Glucocorticoids   -   -   -   -   6件:
40,
41,
43,
44,
60,
62 
 30   Gsk2973327   -   -   -   -   1件:
41 
 31   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 32   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 33   Kevzara ®   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
41 
 34   Kineret   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   5件:
41,
49,
65,
266,
299 
 35   Kpl-301   -   -   -   -   1件:
41 
 36   Mavrilimumab   Mavrilimumab   D09930   1件: CSF2RA   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
41,
46 
 37   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 38   Methotrexate treatment   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   1件:
41 
 39   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 40   Metoject   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   2件:
41,
46 
 41   Naltrexone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 42   Naltrexone hydrochloride   Triamcinolone, Naltrexone, naltrexone hydrochloride   D00385, D00983, D00984, D00985, D02095, D05113, D06216   4件: NR3C1, OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   7件:
10,
40,
41,
42,
43,
44,
45 
 43   Nivolumab   Nivolumab   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97 
 44   Over encapsulated prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
41 
 45   Pet10   -   -   -   -   1件:
41 
 46   Pet3   -   -   -   -   1件:
41 
 47   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 48   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 49   Prednisone and ustekinumab treatment   Ethanol, Ustekinumab   D00068, D02798, D04855, D06542, D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
41 
 50   Prednisone capsules   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
41 
 51   Prednisone tablets usp, 1 mg   Ethanol   D00068, D02798, D04855, D06542   -   -   2件:
41,
46 
 52   Prednisone tablets usp, 2.5 mg   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
41 
 53   Prednisone tablets usp, 5 mg   Ethanol   D00068, D02798, D04855, D06542   -   -   2件:
41,
46 
 54   Prednisone tablets, usp   Ethanol   D00068, D02798, D04855, D06542   -   -   3件:
41,
43,
44 
 55   Prednisone therapy and pharmacokinetic   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
41 
 56   Prednisone treatment   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
41 
 57   Ro 001-9265/f02   -   -   -   -   1件:
41 
 58   Ro 001-9265/f03   -   -   -   -   1件:
41 
 59   Ro 001-9265/f04   -   -   -   -   1件:
41 
 60   Ro 487-7533/f10-04   -   -   -   -   4件:
41,
46,
51,
107 
 61   Roactemra   -   -   -   -   5件:
41,
46,
51,
86,
107 
 62   S78989   -   -   -   -   3件:
41,
50,
56 
 63   Sar153191   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
41,
46,
107,
271 
 64   Sarilumab   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
41,
46,
84,
107 
 65   Sarilumab sar153191   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
41 
 66   Secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   7件:
13,
37,
41,
46,
160,
269,
271 
 67   Secukinumab 300 mg, s.c.   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
41 
 68   Sirukumab   Sirukumab   D10080   1件: IL6   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
41,
46 
 69   Tocilizumab   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 
 70   Tocilizumab + glucocorticoids (gcs)   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   1件:
41 
 71   Tocilizumab sc   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   3件:
41,
46,
107 
 72   Tocilizumab treatment   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   1件:
41 
 73   Treatment   -   -   -   -   1件:
41 
 74   Upadacitinib   Upadacitinib   D10994   1件: JAK1   1件: JAK-STAT signaling pathway   6件:
41,
46,
49,
96,
97,
271 
 75   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 76   Vitamin d   Vitamin D   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 77   Xoma 052   -   -   -   -   5件:
41,
46,
50,
56,
106 

先頭へ